-
Innovation Ranking
NewInnovation Ranking – Meridian Bioscience Inc
Meridian Bioscience Inc (Meridian) is a fully integrated life science company that develops, manufactures and distributes diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. The company also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. It develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office...
-
Innovation Ranking
NewInnovation Ranking – Dare Bioscience Inc
Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations. It offers products that include ovaprene, a clinical stage, non-hormonal contraceptive ring that provides protection over multiple weeks of use; and topical 5% sildenafil citrate cream for women with female sexual arousal...
-
Innovation Ranking
NewInnovation Ranking – Akers Biosciences Inc
MyMD Pharmaceuticals, Inc (MyMD), formerly, Akers Biosciences Inc is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. The company provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell...
-
Innovation Ranking
NewInnovation Ranking – Pacira BioSciences Inc
Pacira BioSciences Inc (Pacira), formerly Pacira Pharmaceuticals Inc, provides non-opioid pain management and regenerative health solutions. The company develops drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic administered at the time of surgery to control pain and eliminate the use of opioids for acute postsurgical pain. Its other products include iovera, a non-opioid treatment intended to block pain, and relieve pain and symptoms related to...
-
Innovation Ranking
NewInnovation Ranking – Harvard Bioscience Inc
Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets instruments, consumables, systems and software. The company’s products include spectrophotometers, plate readers, gel electrophoresis equipment, amino acid analyzers, electroporation and electrofusion instruments, wireless monitors, data acquisition and analysis products and software, and syringe pump and peristaltic pumps, among others. It also provides data analysis, training and installation services. Harvard Bioscience serves research scientists at pharmaceutical and biotechnology companies, hospitals, universities, government laboratories, and contract research organizations. It markets products directly in...
-
Innovation Ranking
NewInnovation Ranking – Coherus BioSciences Inc
Coherus BioSciences Inc (Coherus) is a biopharmaceutical company that conducts research, development and commercialization of immunotherapies to treat cancer. The company markets Udenyca (pegfilgrastim-cbqv), a biosimilar of Neulasta, and Cimerli (ranibizumab-eqrn), a biosimilar of Lucentis, in the US. Coherus products find its application for the treatment of various therapeutic areas which includes nasopharyngeal carcinoma, hepatocellular carcinoma, non-small lung cancer, small cell lung cancer and solid tumors. It is evaluating Toripalimab’s pivotal clinical trial for the treatment of nasopharyngeal carcinoma. The...
-
Innovation Ranking
NewInnovation Ranking – Genocea Biosciences, Inc.
Genocea Biosciences Inc (Genocea), formerly Genocea Inc is a biopharmaceutical company. It develops targeted vaccines and immunotherapies for the treatment of cancer. The company’s pipeline products include Gen-009 and Gen-010, a neoantigen cancer vaccine; Gen-011 is an adoptive T cell therapy. It utilizes ATLAS technology platform that identify immunotherapy targets based on tumor antigen-specific T cell responses. The company develops neoantigen cancer vaccines, general cancer vaccines, and a vaccine targeting cancers caused by epstein-barr virus using its technology platform. Genocea...
-
Innovation Ranking
NewInnovation Ranking – Caladrius Biosciences Inc
Lisata Therapeutics Inc (Lisata Therapeutics), formerly Caladrius Biosciences Inc, is a biopharmaceutical company. It discovers and develops cellular therapies for the treatment of cardiovascular indications and autoimmune diseases. It is investigating XOWNA for the treatment of coronary microvascular dysfunction; HONEDRA against critical limb ischemia and buerger’s disease. The company is also evaluating CLBS201 for the treatment of diabetic kidney disease (DKD); and CLBS14 to treat no-option refractory disabling angina. Lisata Therapeutics utilizes its proprietary CD34+ cell therapy technology to develop...
-
Innovation Ranking
NewInnovation Ranking – Aytu BioScience Inc
Aytu BioPharma Inc (Ayut BioPharma) is a specialty pharmaceutical company that offers prescription therapeutics and consumer health products. Its key prescription products treat attention deficit hyperactivity disorder (ADHD) and other common pediatric conditions. The company markets ADHD products under Adzenys XR-ODT (amphetamine) and Cotempla XR-ODT brands. It also markets ZolpiMist, a short-term treatment for insomnia characterized by difficulties with sleep initiation, Karbinal ER (carbinoxamine maleate), an extended-release carbinoxamine suspension to treat numerous allergic conditions, and Tri-Vi-Flor and Poly-Vi-Flor, two complementary...
-
Innovation Ranking
NewInnovation Ranking – Cellectar Biosciences Inc
Cellectar Biosciences Inc (Cellectar), is a biopharmaceutical company that discovers, develops and commercializes drugs for treatment of cancer. The company’s proprietary technology, phospholipid drug conjugates (PDC) delivery platform develops PDCs for the treatment and diagnosis of cancer. Its lead product includes CLR 131, is a small-molecule PDC, in Phase II clinical trials for the treatment of relapse or refractory multiple myeloma and B-cell lymphomas. The company is also evaluating CLR 131 in Phase I clinical trials for treatment of Pediatric...